Novartis clinical updates pause trials after patient deaths
Novartis said it halted trials for one experimental drug following a spate of patient deaths, while also disclosing positive data for a pill analysts view as a potential blockbuster.
By Mackenzie TatananniNovartis released a mixed bag of clinical updates, pausing trials for one drug after a spate of patient deaths while simultaneously revealing positive data for a pill that analysts view as a potential blockbuster.The Swiss drugmaker said it had halted trials for its experiment…